Transradial Access Products Global Market Report 2025

The transradial access products market size has grown rapidly in recent years. It will grow from $2.2 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, a rising geriatric population, a growing number of cardiovascular disease cases, a higher prevalence of lifestyle-related disorders, and greater awareness of the benefits of radial access.

The transradial access products market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The projected growth in the forecast period can be attributed to the rising demand for minimally invasive surgeries, an increasing number of cancer cases, a growing preference for vascular access devices, a higher prevalence of heart-related diseases and obesity, and the increasing prevalence of chronic diseases. Key trends during this period include advancements in technology for treatment, wider adoption of transradial access techniques, the integration of transradial access devices into clinical practice, the penetration of new technologies, and the development of peripheral intervention technologies.

The growing prevalence of cardiovascular diseases is expected to drive the growth of the transradial access products market in the coming years. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. The rise in cardiovascular diseases is linked to factors including sedentary lifestyles, poor dietary habits, obesity, smoking, excessive alcohol consumption, and an aging population, leading to an increase in hypertension, diabetes, and other risk factors. Transradial access products aid in the treatment of cardiovascular diseases by enabling minimally invasive catheterization procedures, which reduce complications, enhance patient comfort, and speed up recovery. For example, in December 2023, the Australian Institute of Health and Welfare reported that doctor-certified deaths from coronary heart disease (CHD) increased to 14,900 in 2022. This upward trend in cardiovascular diseases is contributing to the growth of the transradial access products market.

The rise in obesity cases is also expected to drive the expansion of the transradial access products market. Obesity is a medical condition defined by the excessive accumulation of body fat, which increases the risk of health issues such as heart disease, diabetes, and hypertension. The increase in obesity rates is attributed to factors such as sedentary lifestyles, high-calorie diets, a higher consumption of processed foods, and less physical activity. Transradial access products benefit individuals with obesity by enabling minimally invasive vascular procedures through the radial artery, reducing complications, enhancing patient comfort, and supporting better clinical outcomes for people with a higher body mass index (BMI). For example, in September 2023, the Centers for Disease Control and Prevention (CDC) reported that 22 states in the U.S. had an adult obesity rate of 35% or higher in 2022, up from 19 states the previous year. The increasing obesity rates are thus contributing to the growth of the transradial access products market.

Companies in the transradial access products market are also focusing on developing innovative products such as peripheral support catheters to improve procedural efficiency and patient outcomes. A peripheral support catheter is a specialized catheter designed to provide extra support and stability during complex peripheral vascular interventions, such as treating chronic total occlusions or navigating tortuous arteries. For example, in December 2024, Terumo Interventional Systems (TIS), a division of Terumo Corporation, launched its R2P NaviCross Peripheral Support Catheter. This product is part of a broader range of interventional products, including catheters, guidewires, sheaths, and other devices used in cardiovascular and peripheral procedures. The R2P NaviCross Peripheral Support Catheter is designed to assist guidewires and improve navigation during challenging peripheral vascular procedures, enabling better access to difficult lesions and areas in peripheral arteries.

Major players in the transradial access products market are Johnson & Johnson, Abbott Vascular, Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Teleflex Incorporated, Cook Medical, Biotronik SE & Co., Smiths Medical, Merit Medical Systems Inc., Penumbra Inc., Angiodynamics Inc., Oscor Inc., Asahi Intecc Co. Ltd., Nipro Medical Corporation, Vascular Solutions Inc., TherOx Inc.

North America was the largest region in the transradial access products market in 2024. The regions covered in transradial access products report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the transradial access products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Transradial access products are medical devices designed to access the circulatory system through the radial artery in the wrist, typically used for procedures such as coronary angiography and angioplasty. This approach is mainly employed in cardiology to gain access to the circulatory system via the radial artery.

The primary types of transradial access products include catheters, guidewires, sheaths, and other devices. A catheter is a flexible medical tube used for fluid delivery, medication administration, or diagnostic purposes during minimally invasive procedures. These products are used in a variety of applications, including diagnostics, interventions, drug delivery, blood transfusions, and other medical procedures. They are utilized by various end users such as hospitals, clinics, ambulatory surgical centers, and other healthcare facilities.

The transradial access products market research report is one of a series of new reports that provides transradial access products market statistics, including the transradial access products industry global market size, regional shares, competitors with the transradial access products market share, detailed transradial access products market segments, market trends, and opportunities, and any further data you may need to thrive in the transradial access products industry. This transradial access products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transradial access products consist of sales of hemostasis devices, radial compression devices, stents, angioplasty balloons, and guidewires. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. e.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.